Table 3. g_mmpdbsa interaction energy and binding free energy of the various protein and ligand complexes used.
Protein | Compound |
|||||
---|---|---|---|---|---|---|
5PGA | ZINC36371307 | ZINC03869631 | ZINC04532950 | ZINC04579000 | ZINC05247724 | |
Cat K | −78.6 ± 0.2 | −113.0 ± 0.2 | −99.2 ± 0.1 | −91.8 ± 0.2 | −81.3 ± 0.2 | −93.4 ± 0.2 |
Cat L | −93.2 ± 0.2 | −88.4 ± 0.1 | −96.7 ± 0.2 | −136.7 ± 0.2 | −99.4 ± 0.2 | −125.0 ± 0.2 |
FP-2 | −86.7 ± 0.1 | −81.2 ± 0.1 | −86.7 ± 0.2 | −83.8 ± 0.2 | −70.6 ± 0.2 | −80.1 ± 0.2 |
FP-3 | −62.1 ± 0.2 | −93.1 ± 0.2 | −91.4 ± 0.2 | −96.7 ± 0.2 | −102.3 ± 0.2 | −92.1 ± 0.2 |
VP-2 | −65.3 ± 0.2 | −101.7 ± 0.2 | −91.3 ± 0.2 | −92.3 ± 0.2 | −81.6 ± 0.2 | −107.9 ± 0.2 |
VP-3 | −71.5 ± 0.1 | −78.2 ± 0.2 | −66.8 ± 0.2 | −73.9 ± 0.2 | −121.7 ± 0.7 | −101.7 ± 0.2 |
KP-2 | −68.2 ± 0.2 | −109.9 ± 0.2 | −91.4 ± 0.2 | −81.9 ± 0.2 | −68.0 ± 0.2 | −71.5 ± 0.1 |
KP-3 | −44.5 ± 0.2 | −81.8 ± 0.2 | −68.2 ± 0.2 | −55.3 ± 0.2 | −70.6 ± 0.1 | −69.8 ± 0.2 |
BP-2 | −65.6 ± 0.2 | −90.1 ± 0.2 | −92.7 ± 0.2 | −84.0 ± 0.2 | −74.2 ± 0.2 | −82.7 ± 0.2 |
CP-2 | −75.4 ± 0.1 | −89.8 ± 0.2 | −100.2 ± 0.2 | −103.0 ± 0.2 | −119.1 ± 0.3 | −91.8 ± 0.2 |
YP-2 | −62.9 ± 0.2 | −76.6 ± 0.2 | −84.7 ± 0.1 | −96.7 ± 0.2 | −86.4 ± 0.2 | −79.3 ± 0.1 |